Diabetes Research Centers (P30 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is inviting applications for the Diabetes Research Centers (P30 Clinical Trial Optional) grant, aimed at enhancing national research efforts in diabetes and related diseases. This funding opportunity encourages collaboration among basic and clinical researchers by providing shared technical resources and a Pilot and Feasibility Program, with a focus on innovative approaches and synergies with other NIDDK-funded programs. Eligible applicants include various higher education institutions, nonprofits, and government entities, with a maximum project period of five years and an award ceiling of $1 million, or $1.25 million for those proposing a Regional/National Shared Research Core. Interested parties should note that only one application per institution is permitted, and the application deadline is January 27, 2027. For further inquiries, contact the Division of Diabetes, Endocrinology and Metabolic Diseases at NIDDK_DEM@nih.gov.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Special Instructions for this NOFO: Only one application is allowed per institution.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.